Mick Farrell, Resmed Chairman and CEO to deliver opening remarks and contribute his perspective as part of a keynote panel on the future of AI in healthcare.
SAN DIEGO, September 29, 2025 -Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, will feature multiple speakers at the AdvaMed MedTech conference. Mick Farell, Chairman and CEO, will deliver opening remarks and take the stage at the keynote luncheon with fellow industry leaders to discuss how artificial intelligence is transforming patient care and redefining the future of MedTech innovation.
See below details for Mick Farrell's featured sessions at the conference.
Global Welcome Reception Opening Remarks
Speaker: Mick Farrell, Chairman and Chief Executive Officer
Date: Sunday, October 5 | 6:00 - 8:00 p.m. PT
Agents of Change: Redefining the Future of Healthcare Through AI
Speaker: Mick Farrell, Chairman and Chief Executive Officer
Date: Tuesday, October 7 | 12:20 - 1:25 p.m. PT
CEOs Unplugged: How MedTech Leaders Are Unlocking Transformative Innovation for Value Creation
Speaker: Mick Farrell, Chairman and Chief Executive Officer
Date: Tuesday, October 7 | 1:45 - 2:15 p.m. PT
Resmed leaders will also participate in sessions covering key industry topics, including medical technology innovation, reimbursement challenges, real-world evidence for health equity, AI in healthcare, and patient-centered care. Additional Resmed speaker sessions are noted below.
Sleep, Tech and Transformation: One Patient's CPAP Story with Dr. Carlos Nunez
Moderator: Carlos Nunez, Chief Medical Officer
Date: Monday, October 6 | 11:15 - 11:30 a.m. PT
Hospital at Home: Opportunities for Medtech Innovation and Partnership
Speaker: Amanda von Leer, Vice President, Global Government Affairs & Policy
Date: Monday, October 6 | 2:00 - 3:00 p.m. PT
Leveraging Real-World Evidence (RWE) for Health Access: Inclusive Benefits for All
Speaker: Will McConnell, Director, Center of Excellence for Real World Evidence
Date: Monday, October 6 | 3:15 - 4:15 p.m. PT
Corporate Reverse Pitch Presentation: Resmed
Speaker: Grant Olsen, Vice President, M&A and Ventures
Date: Tuesday, October 7 | 2:45 - 3:00 p.m. PT
Resmed sponsorship highlights:
Patient Pavilion Participant
Career Hub Recruiter Table
Tech In Motion Display Kiosk
MedTech Color Breakfast Event Sponsor
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We're relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we're redefining sleep health at Resmed.com and follow @Resmed.
For MediaCaela ShayCaela.shay@resmed.comnews@resmed.com
For Investors Salli SchwartzSalli.Schwartz@resmed.cominvestorrelations@resmed.com
Attachments
Original document
Permalink
Disclaimer
ResMed Inc. published this content on September 29, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 29, 2025 at 16:10 UTC.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (51.8%);
- masks (35.7%);
- software as a service (12.5%): residential care management software solutions.
At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France.
The United States accounts for 63.8% of net sales.
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
